Unknown PHASE3 INTERVENTIONAL 2-arm NCT03662269

Indomethacin for Refractory Chronic Cough

Indomethacin for Refractory Chronic Cough: a Randomized, Double-blind, Placebo-controlled Trial

Sponsor: The First Affiliated Hospital of Guangzhou Medical University

Interventions Omeprazole Placebo indomethacin

Updated 5 times since 2018 Last updated: Nov 22, 2018 Started: Oct 22, 2018 Primary completion: Aug 15, 2020 Completion: Dec 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Refractory Chronic Cough, this trial is ongoing. The trial is conducted by The First Affiliated Hospital of Guangzhou Medical University and has accumulated 5 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status
Dec 2018 — Jan 2021 [monthly]

Recruiting PHASE3
Oct 2018 — Dec 2018 [monthly]

Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The First Affiliated Hospital of Guangzhou Medical University

Data source: The First Affiliated Hospital of Guangzhou Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China